2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections
US-9700560-B2 · Jul 11, 2017 · US
US10995093B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10995093-B2 |
| Application number | US-201916699427-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2019 |
| Priority date | Apr 7, 2016 |
| Publication date | May 4, 2021 |
| Grant date | May 4, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides a new convergent approach for the synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) and 2′-fluoro-6′-methylene-carbocyclic guanosine (FMCG) from a readily available starting material in eight steps. An efficient and practical methodology for stereospecific preparation of a versatile carbocyclic key intermediate, (1S,3R, 4R)-3-tert-butoxy-4-(tert-butoxymethyl)-2-fluoro-5-methylenecyclopentanol (compound 8 of scheme 1A or a) in only six (6) steps is also provided. Prodrugs of these compounds are also prepared.
Opening claim text (preview).
What is claimed is: 1. A process for preparing the compound 2′-Fluoro-6′-Methylene-Carbocyclic Adenosine (FMCA) compound 10 from compound 8 Comprising condensing an amine protected 6-amino purine compound according to the chemical structure: where P represents one or two amine protecting groups (preferably two BOC groups) onto compound 8 in the presence of triphenylphosphine and diisopropylazidocarboxylate (DIAD) in solvent to produce compound 8P where P represents one or two amine protecting groups; and subjecting compound 8P to deprotection to produce compound 10 (FMCA) wherein the synthesis is conducted in steps, wherein both compound 8P and 10 are separated and purified. 2. A process for preparing the compound 2′-Fluoro-6′-Methylene-Carbocyclic Adenosine (FMCA) compound 10 from compound 8 Comprising condensing a di-Boc protected 6-amino purine compound according to the chemical structure: onto compound 8 in the presence of triphenylphosphine and diisopropylazidocarboxylate (DIAD) in solvent to produce compound 9 subjecting compound 9 to deprotection to produce compound 10 (FMCA) wherein the synthesis is conducted in steps, wherein compounds 9 and 10 are separated and purified. 3. Any one or more of compounds 3, 4, 5, 6, 7, 8, 8P, 9, 9P or 9G hereof or a salt thereof.
ortho- or peri-condensed with carbocyclic rings or ring systems · CPC title
with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both · CPC title
containing hydroxy or O-metal groups · CPC title
for DNA viruses · CPC title
one oxygen and one nitrogen atom, e.g. guanine · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.